Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Inv. presentation
PHARMACYCLICS INC (PCYC) Create: Alert

All | News | Filings
Date FiledTypeDescription
06/10/2015 SC 13G/A PRICE T ROWE ASSOCIATES INC reports a 0% stake in PHARMACYCLICS INC
06/01/2015 SC 13D/A DUGGAN ROBERT W reports a 0% stake in Pharmacyclics, Inc.
05/26/2015 8-K Form 8-K - Current report
05/26/2015 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
05/22/2015 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
05/21/2015 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
05/15/2015 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
05/14/2015 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
05/14/2015 425 Form 425 - Prospectuses and communications, business combinations
05/08/2015 425 Form 425 - Prospectuses and communications, business combinations
05/07/2015 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
05/07/2015 425 Form 425 - Prospectuses and communications, business combinations
05/04/2015 10-Q Quarterly Report for the period ended March 31, 2015
05/01/2015 8-K Quarterly results
Docs: "Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates"
05/01/2015 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
04/24/2015 425 Form 425 - Prospectuses and communications, business combinations
04/23/2015 425 Form 425 - Prospectuses and communications, business combinations
04/17/2015 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
04/17/2015 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
04/10/2015 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
04/08/2015 10-K/A Annual Report for the period ended December 31, 2014 [amend]
04/08/2015 425 Form 425 - Prospectuses and communications, business combinations
03/30/2015 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
03/30/2015 425 Form 425 - Prospectuses and communications, business combinations
03/23/2015 SC 14D9 Form SC 14D9 - Solicitation, recommendation statements:
03/23/2015 SC TO-T Form SC TO-T - Tender offer statement by Third Party:
03/23/2015 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
03/23/2015 425 Form 425 - Prospectuses and communications, business combinations
03/23/2015 425 Form 425 - Prospectuses and communications, business combinations
03/16/2015 8-K Other Events, Financial Statements and Exhibits
Docs: "Independent Data Monitoring Committee Unanimously Recommends Unblinding of IMBRUVICA® (ibrutinib) Phase III Combination HELIOS Trial Based on Interim Analysis Showing Significant Improvement in Progression-Free Survival in Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma"
03/09/2015 SC 13D/A DUGGAN ROBERT W reports a 17.8% stake in Pharmacyclics, Inc.
03/06/2015 425 Form 425 - Prospectuses and communications, business combinations
03/06/2015 SC14D9C Form SC14D9C - Written communication relating to third party tender offer:
03/06/2015 8-K Entry into a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointment of...
Docs: "Agreement and Plan of Reorganization, by and among by and among AbbVie Inc., Oxford Amherst Corporation, Oxford Amherst LLC and Pharmacyclics, Inc",
"Amendment to Amended and Restated Bylaws of Pharmacyclics, Inc",
"Support Agreement",
"Form of Pharmacyclics, Inc. Change in Control and Severance Plan"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy